The Challenge of CMC Regulatory Compliance for Biopharmaceuticals - John Geigert - Books - Springer Nature Switzerland AG - 9783032252821 - July 3, 2026
In case cover and title do not match, the title is correct

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals Fifth Edition 2026 edition

Regulatory authorities, primarily the U.S. FDA and the European EMA, have responded to this increasing CMC regulatory compliance complexity of biopharmaceuticals, and have issued over 150 new or updated regulatory guidelines since the publishing of the previous edition.

Media Books     Hardcover Book   (Book with hard spine and cover)
Released July 3, 2026
ISBN13 9783032252821
Publishers Springer Nature Switzerland AG
Pages 629
Dimensions 150 × 220 × 20 mm   ·   1.14 kg
Language German  

More from the same publisher